AstraZeneca expands coronavirus vaccine deal
Oxford Biomedica said in a statement that AstraZeneca would give it 15 million pounds ($20 million) upfront to reserve manufacturing ...
Oxford Biomedica said in a statement that AstraZeneca would give it 15 million pounds ($20 million) upfront to reserve manufacturing ...
The Financial Times reported that Washington was considering basing emergency approval of the vaccine on just a small UK study ...
According to the announcement by Belarusian presidency, the country's citizens will take part in the 3d phase of Russian coronavirus ...
The news comes as Italy registered a further increase in new infections on Sunday, confirming the surging trend in contagions ...
Major state-owned Chinese pharmaceutical company Sinopharm, which has two vaccines in trial, has reported an annual manufacturing capacity of 220 ...
Professor Alexander Chuchalin on Thursday resigned after criticizing the new Sputnik V drug being rolled out before the body approved ...
Russian President Vladimir Putin said that coronavirus vaccine developed by Gamaleya Research Center is registered by the country's Health Ministry.
Both Russian vaccines are planned to enter mass production early this fall amid the third phase of trials.
According to a report, Russia plans to register a coronavirus vaccine as soon as 10 August to 15 August.
The agreement will cover the treatment of approximately 30,000 patients with severe symptoms of the novel coronavirus.